Leaflet OCTAPLASLG 45-70mg / ml solution for infusion


Indicated for: plasma factor replacement; coagulopathy

Substance: human plasma proteins of blood group A, B, AB, 0 (plasma expander)

ATC: B05AA (Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions)


Human plasma proteins of blood groups A, B, AB, 0 are used for various medical purposes, including plasma replacement therapies.
They contain clotting factors, immunoglobulins, and other essential proteins necessary for normal body function.

They are particularly used in cases of massive blood loss, coagulation disorders, or immune deficiencies.
They may also be administered in treatments for severe burns or during major surgical procedures.

Side effects may include allergic reactions, fever, or, in rare cases, infections transmitted through plasma.
It is essential to perform compatibility tests before administration and monitor the patient during treatment.

General data about OCTAPLASLG 45-70mg / ml

  • Substance: human plasma proteins of blood group A, B, AB, 0
  • Commercial code: W65357001
  • Concentration: 45-70mg / ml
  • Pharmaceutical form: solution for infusion
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: OCTAPHARMA AB - SUEDIA
  • Holder: OCTAPHARMA (IP) SPRL - BELGIA
  • Number: 13602/2020/01
  • Shelf life: 4 years